Schoneveld et al. (43) retrospectively analyzed serum CHI3L1 levels in patients with coronavirus disease 2019 (COVID-19), chronic obstructive pulmonary disease, and unrelated interstitial lung disease and found that CHI3L1 upregulation in patients was strongly associated with the level of inflammation. This evidence concerns the gene CHI3L1 and COVID-19.